Global Neonatal Point Of Care Testing Market
Medical Equipment

Neonatal Point Of Care Testing Market Outlook: Growth and Forecast Highlights 2030

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Neonatal Point Of Care Testing Market show for the 2026–2030 period?

The neonatal point of care testing market has experienced rapid expansion in recent years. Its valuation is anticipated to increase from $1.32 billion in 2025 to $1.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.5%. The historical growth of this market can be attributed to factors like heightened awareness of neonatal mortality, the adoption of swift testing devices within hospitals, governmental assistance for neonatal care, the growth of maternity clinics, and enhancements in bedside testing technologies.

The neonatal point of care testing market is forecast to undergo substantial expansion in the coming years. By 2030, its value is expected to reach $2.59 billion, achieving a compound annual growth rate (CAGR) of 14.3%. This projected growth stems from factors such as the development of AI-based diagnostic solutions, cloud integration for managing neonatal data, the availability of portable and compact point-of-care devices, an increase in private-public partnerships concerning newborn health, and improvements in neonatal healthcare infrastructure within emerging economies. Important trends for this forecast period encompass AI-enabled neonatal diagnostics, cloud-based point-of-care platforms, portable testing devices, real-time data analysis, and the integration of IoT for monitoring newborns.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28277&type=smp

What Drivers Are Shaping The Development Of The Neonatal Point Of Care Testing Market?

The escalating need for remote patient monitoring is anticipated to propel the growth of the neonatal point of care testing market moving forward. This form of monitoring involves delivering healthcare services through technology, connecting patients with medical professionals from a distance. The demand for remote patient monitoring is increasing due to the heightened requirement for accessible and convenient medical care, particularly for individuals residing in remote or underserved regions. Neonatal point-of-care testing significantly aids remote patient monitoring by offering immediate diagnostic results at the bedside, which allows healthcare providers to quickly identify and manage critical conditions in newborns without the reliance on a central laboratory. For instance, in August 2023, Vivalink, a US-based healthcare technology company, reported through a recent survey that 84% of current remote patient monitoring (RPM) users intend to expand their utilization in 2024, while 45% of healthcare providers are using RPM for acute monitoring in hospital-at-home programs, and 77% believe that RPM-based care will supersede traditional inpatient hospital care within the next five years. Thus, the growing demand for remote patient monitoring is projected to drive the expansion of the neonatal point of care testing market.

What Segment Types Are Examined In The Neonatal Point Of Care Testing Market?

The neonatal point of care testing market covered in this report is segmented –

1) By Product: Instruments, Assay

2) By Test Type: Neonatal Bilirubin Testing, Blood Glucose Testing, Infectious Disease Screening, Electrolyte Testing, Other Test Types

3) By End-Users: Hospitals, Maternity And Specialty Clinics, Other End-Users

Subsegments:

1) By Instruments: Blood Gas Analyzers, Bilirubinometers, Glucose Meters

2) By Assay: Bilirubin Assays, Glucose Assays, Infectious Disease Assays, Electrolyte Assays, Blood Gas Assays

What Industry Trends Are Transforming The Neonatal Point Of Care Testing Market?

Key players in the neonatal point of care testing market are concentrating on forging strategic collaborations to allow for more efficient access to new markets and broader customer bases. Such strategic collaborations involve alliances between organizations that combine their resources and expertise to achieve mutual business objectives. For example, in January 2025, QIAGEN, a Netherlands-based provider of sample and assay technologies, entered into a partnership with Genomics England, a UK-based genomic medicine company. This collaboration has led to the introduction of the Generation Study, an endeavor that will sequence the genomes of 100,000 newborns in England to screen for more than 200 actionable genetic conditions. QIAGEN will contribute unique clinically relevant variant information pertaining to the genes included in the point-of-care sequencing test. This information will enable quicker interpretation and reporting of sequencing results, thereby assisting in the earlier detection and treatment of rare conditions. The study, officially beginning in October 2024, focuses on conditions that might affect approximately 3,000 newborns annually in the UK.

Who Are The Major Companies Operating In The Neonatal Point Of Care Testing Market?

Major companies operating in the neonatal point of care testing market are Abbott Laboratories, Siemens Healthineers AG, GE Healthcare Technologies Inc., Koninklijke Philips N.V., Roche Diagnostics International AG, Danaher Corporation, Dräger AG & Co. KGaA, Masimo Corporation, Radiometer Medical ApS, Nova Biomedical Corporation, bioMérieux SA, Sysmex Corporation, Nihon Kohden Corporation, Natus Medical Incorporated, Contec Medical Systems Co. Ltd., Edan Instruments Inc., Trivitron Healthcare, Bistos Co. Ltd., Bilimetrix S.r.l., GINEVRI Srl

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/neonatal-point-of-care-testing-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Neonatal Point Of Care Testing Market?

North America was the largest region in the neonatal point of care testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal point of care testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Neonatal Point Of Care Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28277&type=smp

Browse Through More Reports Similar to the Global Neonatal Point Of Care Testing Market 2026, By The Business Research Company

Pediatric And Neonatal Testing Kit Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pediatric-and-neonatal-testing-kit-global-market-report

Prenatal Testing And Newborn Screening Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Prenatal And Newborn Genetic Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company